Thorsten Derlin
Papers
1
Total Citations
3
H-Index
1
About
Thorsten Derlin is a leading figure in the field of nuclear medicine and molecular imaging, with a primary research focus on the development and clinical translation of novel theranostic approaches for prostate cancer. His major contributions center on advancing radioguided surgery (RGS), particularly through the use of prostate-specific membrane antigen (PSMA)-targeted tracers. His highly cited 2024 work, "Feasibility of Using a Novel Drop-In Gamma Probe for 99mTc-PSMA-I&S–Guided Lymph Node Detection During Robot-Assisted Radical Prostatectomy," demonstrates his pivotal role in refining surgical precision. This study, which has already garnered significant early attention, evaluates the practical application of a new drop-in gamma probe for intraoperative detection of PSMA-avid lymph node metastases, directly addressing a critical need for more accurate staging in primary prostate cancer. By systematically assessing the feasibility, safety, and limitations of this technique, Derlin provides essential data that bridges the gap between advanced imaging and surgical intervention. His work is instrumental in moving PSMA-targeted RGS from a promising concept toward a standardized clinical tool, ultimately aiming to improve oncological outcomes for patients.
Research Focus
Key Achievements
Top Papers
- 1